Assessment of Therapy Complications
Assessment of Therapy Complications is a medical procedure with 64 clinical trials. Currently 3 active trials ongoing. Historical success rate of 85.4%.
Success Metrics
Based on 41 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
3
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
83.7%
41 of 49 finished
16.3%
8 ended early
3
trials recruiting
64
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer
Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer
Clinical Trials (64)
Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer
Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride
Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel
Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Supportive Intervention Programs Study
Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery
Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 64